Planet Labs vs Relay Therapeutics Inc. Common Stock — how do they compare? Planet Labs trades at $17.52 (market cap $6.46B), while Relay Therapeutics Inc. Common Stock trades at $17.39 (market cap $3.94B). The key difference: Planet Labs is the larger of the two by market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Planet Labs nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Planet Labs for 4 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| PL | RLAY | |
|---|---|---|
Market Cap | $6.46B | $3.94B |
Volume | 10,188,839 | 3,432,928 |
Sector | Industrials | Health |
52-Week High | $51.40 | $20.75 |
52-Week Low | $11.16 | $6.03 |
Typical Hold Time | 4 Days | 0 Days |
Enterprise Value | $6.09B | $3.06B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Planet Labs operates Earth-imaging satellites and provides geospatial data products. Its imagery and analytics help governments and businesses monitor changes across the planet.
Read more on PL →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →